Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Conmed (CNMD) Debt to Equity (2016 - 2025)

Conmed's Debt to Equity history spans 16 years, with the latest figure at $0.81 for Q4 2025.

  • For Q4 2025, Debt to Equity fell 14.1% year-over-year to $0.81; the TTM value through Dec 2025 reached $0.81, down 14.1%, while the annual FY2025 figure was $0.81, 14.1% down from the prior year.
  • Debt to Equity reached $0.81 in Q4 2025 per CNMD's latest filing, down from $0.85 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $1.46 in Q2 2022 to a low of $0.81 in Q4 2025.
  • Average Debt to Equity over 5 years is $1.09, with a median of $1.02 recorded in 2021.
  • Peak YoY movement for Debt to Equity: skyrocketed 62.31% in 2022, then fell 21.28% in 2025.
  • A 5-year view of Debt to Equity shows it stood at $0.87 in 2021, then soared by 62.31% to $1.41 in 2022, then dropped by 17.49% to $1.17 in 2023, then fell by 19.4% to $0.94 in 2024, then fell by 14.1% to $0.81 in 2025.
  • Per Business Quant, the three most recent readings for CNMD's Debt to Equity are $0.81 (Q4 2025), $0.85 (Q3 2025), and $0.88 (Q2 2025).